• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

pitch

Biomimesys

HCS Pharma will attend RDV Carnot and will pitch there

Dear all, please feel free to contact Elodie who will be in RDV Carnot event in Paris (Espace Champerret, 17e arrondissement) tomorrow and on Thursday. Since HCS Pharma was selected as a laureate amongst innovative start-ups and SMEs for this ecent, she will be the first to pitch at 11:40 Read more…

By Elodie Vandenhaute, 4 monthsOctober 11, 2022 ago
News

HCS Pharma selected in Female Founder Challenge of Vivatechnology

Among 370 applications from 54 countries, I am proud to be selected with 9 other start-ups for Female Founder Challenge organized by Vivatechnology & 50inTech. We are to women frmn France. “In Europe, 92% of the funds were invested in startups founded by men. The tech sector needs to be Read more…

By Nathalie MAUBON, 3 yearsJune 11, 2020 ago
HCS, HCA & Biology

Our feed-back of “universités d’été” organised by AFSSI in DIJON

It was really interesting to be present at the AFSSI’s “universités d’été”. About 160 business heads of CRO (contract research organisation) in biotechnology area were present. We were also lucky to present our business during the elevator pitch, 5 min to convince, during the 2nd day.

By Nathalie MAUBON, 8 yearsJuly 13, 2015 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • New 3D in vitro model of dysbiosis-induced colon cancer thanks to France Relance Plan
  • Retrospective HCS Pharma 2022
  • Animal tests no longer necessary before drug clinical trials? Let’s make it in 3D in preclinical studies… and with the extracellular matrix!
  • Tokyo Future Style Taiwan presented our BIOMIMESYS® products during Taiwan Healthcare Expo 2022
  • We were in Cosmet’Agora last week !
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid hydroscaffold imaging innovation in vitro in vitro models liver meeting Microbiota microscopy Molecular Devices NEUROCELL3D neurons neurotoxicity oncology organoids Parkinson phenotypic screening picture presentation screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...